We design bespoke ADME protocols optimized for complex modalities, ensuring that non-traditional structures receive the specific analytical attention required for accurate profiling.
In Vitro ADME One Stop Solutions
Creative Biolabs delivers an integrated laboratory platform specifically designed for assessing the absorption, distribution, metabolism, and excretion of novel drug candidates. By combining high-efficiency screening workflows with sophisticated 3D cellular models, we enable a deeper characterization of compound behavior within biological systems. Our clients gain access to vital insights regarding metabolic stability, membrane permeability, and potential drug-drug interactions. These data facilitate more informed decision-making throughout the lead optimization phase, ultimately enhancing the selection of high-quality candidates and improving the success rate of your research programs.
Introduction What We Can Offer How We Can Help Why Choose Us Customer Reviews FAQs Related Services Contact Us
Comprehensive Integrated Platforms for Advanced ADME Characterization
Modern research into human cancer and metabolic processes has transitioned from basic 2D cell monolayers toward sophisticated microphysiological platforms. Current drug discovery requires high-fidelity environments that accurately replicate human vascular dynamics and immune aging factors. Creative Biolabs leverages these biological advancements to deliver predictive ADME data. By integrating intelligent microfluidics with industrial-scale automation, we bridge the critical gap between laboratory leads and development success, ensuring that only the most robust and viable candidates move forward in the pipeline.
Request a Consultation →
Fig.1 In vitro ADME: tumor-reactive T cell expansion and organoid killing. 1
What We Can Offer
Customized Assay Development
High-Throughput Industrial Scale
Our facility features automated screening lines capable of processing hundreds of compounds weekly, delivering rapid turnaround times and consistent data quality for large-scale library evaluations.
Metabolic Characterization
Our team performs detailed reaction phenotyping across major metabolic pathways, identifying critical biotransformation routes and metabolic "soft spots" to guide compound structural optimization.
Intelligent Data Analysis
By leveraging real-time data processing, we analyze drug-barrier interactions with high sensitivity, providing deeper insights into cellular attachment and dynamic compound movement within biological systems.
How Creative Biolabs' service Can Assist Your Projects
Creative Biolabs offers a comprehensive in vitro absorption, distribution, metabolism, and excretion (ADME) service for cancer immunotherapy, which includes various critical components to support drug development for cancer immunotherapy.
From absorption and distribution studies to metabolism and excretion analyses, we cover every critical aspect to ensure your success. For comprehensive details on each service, please follow the link below:
Creative Biolabs also offers specialized sub-services to de-risk your pipeline at the molecular level. Our intrinsic clearance services cover key enzymes including CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, and 3A4, alongside comprehensive UGT Phenotyping. To ensure safety, we provide cytotoxicity screening across diverse cell lines and evaluate transporter substrates. We also offer nuclear receptor assays and definitive cell viability measurements.
Metabolic Stability & Phenotyping →
In Vitro CYP2C9 Intrinsic Clearance Measurement In Vitro CYP2C19 Intrinsic Clearance Measurement In Vitro CYP2D6 Intrinsic Clearance Measurement In Vitro CYP3A4 Intrinsic Clearance Measurement In Vitro CYP2C8 Intrinsic Clearance Measurement In Vitro CYP2B6 Intrinsic Clearance Measurement In Vitro CYP1A2 Intrinsic Clearance Measurement UGT Phenotyping Assay
Cytotoxicity & Safety Screening →
BJ Cell-based Cytotoxicity Safety Screening HEK293-based Cytotoxicity Safety Screening H4-II-E-C3-based Cytotoxicity Safety Screening HepG2-based Cytotoxicity Safety Screening HUVEC-based Cytotoxicity Safety Screening Jurkat Cell-based Cytotoxicity Safety Screening MRC-5-based Cytotoxicity Safety Screening Neuro-2a-based Cytotoxicity Safety Screening NIH/3T3-based Cytotoxicity Safety Screening NRK-52E-based Cytotoxicity Safety Screening SH-SY5Y-based Cytotoxicity Safety Screening SK-N-SH-based Cytotoxicity Safety Screening HK-2-based Cytotoxicity Safety Screening Cell Viability Measurement
Nuclear Receptor Assays →
Integrated ADME & Toxicology →
Highlights
Personalized Immunotherapy & Biomarker Identification
We tailor ADME profiles for individual patients and identify key metabolic biomarkers, enabling the creation of personalized cancer treatments and accurate prediction of therapeutic responses.
Combination Therapy & Synergetic Evaluation
Our experts evaluate the complex disposition of combination therapies to ensure optimal drug interactions, maximizing the synergistic effects and overall efficacy of cancer treatment protocols.
Innovative Delivery & Bioavailability Optimization
We assist in the development of next-generation drug delivery systems to significantly enhance the bioavailability and targeted delivery of advanced cancer immunotherapies to specific biological sites.
Comprehensive Risk Mitigation & Safety Assessment
We conduct thorough early-stage safety assessments to identify and mitigate potential metabolic risks, ensuring the long-term viability and clinical safety of your drug candidates.
Get a Quote→
Customer Reviews
-
Improved Predictivity in CNS Research
By utilizing Creative Biolabs' specialized Brain Tissue Binding assays, we successfully overcame persistent challenges in modeling blood-brain barrier penetration, leading to exceptional alignment between our initial in vitro screenings and subsequent laboratory outcomes. - Dr. E**n. V. -
Robust Data Packages
The automated analytical platform delivered a high-quality interaction package that met all internal project milestones. Their reliable bioanalysis provided the clear, reproducible evidence needed to advance our lead compounds confidently. - M. A***a. D.
FAQs
Can your platform predict Cytokine Release potential?
Our safety suite monitors cytokine dynamics within humanized 3D models to assess release risks. This proactive screening identifies potential liabilities early, ensuring your immunotherapies are characterized for safety.
Are your data packages suitable for research reports?
Our assays are conducted following established laboratory guidelines to ensure high data quality. These robust packages are specifically formatted for seamless inclusion in your internal research and development reports.
Related Services
In Vitro ADME
We evaluate drug behavior within the tumor microenvironment, specifically measuring how therapeutic agents interact with immune cells to optimize immuno-oncology outcomes.
Learn More →In Vivo Drug Metabolism and Pharmacokinetics (DMPK) Service
We provide advanced animal studies to assess drug distribution and metabolic kinetics, bridging the gap between cell-based assays and clinical success.
Learn More →How to Contact Us
Creative Biolabs provides the comprehensive tools, specialized expertise, and validated methodologies required to transform your drug discovery pipeline into a high-efficiency engine. Our integrated approach ensures that every assay contributes to a holistic understanding of your compound's biological fate.
Our scientists are ready to collaborate with you to design a tailored ADME strategy that fits your unique project requirements - contact us.
Reference
- Choi, Jane Ru et al. "In Vitro Human Cancer Models for Biomedical Applications." Cancers vol. 14,9 2284. 3 May. 2022. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cancers14092284
Download our brochureLoading case studies...
Online Inquiry